Avita Medical
RCEL
68 hedge funds and large institutions have $48.3M invested in Avita Medical in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 25 closing their positions.
37% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 19
4.83% less ownership
Funds ownership: 28.47% → 23.64% (-4.8%)
17% less funds holding
Funds holding: 82 → 68 (-14)
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
59% less capital invested
Capital invested by funds: $117M → $48.3M (-$69M)
69% less call options, than puts
Call options by funds: $117K | Put options by funds: $377K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.83M |
| 2 |
Morgan Stanley
New York
|
+$655K |
| 3 |
Jane Street
New York
|
+$517K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$410K |
| 5 |
D.E. Shaw & Co
New York
|
+$349K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$4.12M |
| 2 |
AIC
AWM Investment Company
New York
|
-$4.03M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$3.87M |
| 4 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
-$2.33M |
| 5 |
GC
Globeflex Capital
San Diego,
California
|
-$1.23M |
RCEL Hedge Fund Activity: Q2 2024 in Review
68 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q2 2024, worth a combined $48.3M — down 59% from $117M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of RCEL and 13 opened new positions — a net loss of 12 holders — while 19 trimmed existing stakes and 26 added.
The largest buyer was Soleus Capital Management, adding an estimated $1.83M. The largest seller was State Street, cutting an estimated $4.12M.
- 68 institutional investors held Avita Medical (RCEL) as of Q2 2024, down from 82 in Q1 2024.
- Funds reported $48.3M of Avita Medical stock for Q2 2024, down 59% quarter-over-quarter.
- 13 funds opened new Avita Medical positions in Q2 2024 and 25 closed out, a net change of -12 holders.
- The largest Avita Medical buyer in Q2 2024 was Soleus Capital Management, an estimated $1.83M added.
- The largest Avita Medical seller in Q2 2024 was State Street, an estimated $4.12M sold.
Based on aggregated 13F filings for Q2 2024.